In The News: GRAM Supports Manufacturing of COVID-19 Vaccine
Since September 2020, GRAM has been proudly supporting the manufacture of Johnson & Johnson’s SARS-CoV-2 vaccine by providing fill and finish services. When the vaccine received emergency use authorization from the Food and Drug Administration in late February 2021, GRAM made headlines as the West Michigan-based CDMO helping ensure that vaccine supply is available.
Check out a few of the places where GRAM and its executives were featured in the news:
WOOD TV: GR company producing J&J vaccine ready for FDA approval
“I don’t know if a lot of people have realized that there’s a pharma company here [in Grand Rapids] that is contributing to this mission right now,” Steven Nole, vice president of operations for GRAM, said.
Fox 17: West Michigan company plays part in Johnson & Johnson manufacturing
“This is the type of thing you tell your grandkids about,” said Grand River Aseptic Manufacturing president & CEO Tom Ross.
MiBiz: GRAM ramps up production of Johnson & Johnson’s COVID-19 vaccine following FDA approval
Grand River Aseptic has worked with J&J “tirelessly and endlessly on an accelerated timeline” to produce a vaccine for COVID-19 that “meets the same quality and safety standards that we’ve always upheld,” Ross said.
WMMT: Grand River Aseptic Manufacturing gearing up for COVID-19 vaccine shipments
“I … couldn’t be more proud of the entire team at our company. Everybody has been working really hard. When they say Operation Warp Speed it has been Operation Warp Speed and that’s a good thing and we’re growing,” Grand River Aseptic Manufacturing vice president of client pharmaceutical services John Wichelt said.
MLive.com: ‘Everybody’s stepped up,’ says rep at Grand Rapids company making Johnson & Johnson COVID-19 vaccine
“This is just a new paradigm for the whole industry,’’ [David] Powell [GRAM’s vice president of business development] said. “We are accelerating everything. That’s been the biggest change.”
As we continue to support Johnson & Johnson and the U.S.’s pharmaceutical response to COVID-19, GRAM is incredibly proud of what our team has accomplished over the past year to play a significant role in saving lives.
Learn more about GRAM’s fill and finish facilities here.